Complexed Hyaluronic Acid-Based Nanoparticles in Cancer Therapy and Diagnosis: Research Trends by Natural Language Processing DOI Creative Commons
Abd. Kakhar Umar, Patanachai Limpikirati,

Bachtiar Rivai

et al.

Heliyon, Journal Year: 2024, Volume and Issue: 11(1), P. e41246 - e41246

Published: Dec. 18, 2024

Language: Английский

Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation DOI Creative Commons

Juwita N. Rahmat,

Jiayi Liu,

Taili Chen

et al.

Chemical Society Reviews, Journal Year: 2024, Volume and Issue: 53(11), P. 5862 - 5903

Published: Jan. 1, 2024

Schematic of the immunomodulatory approaches for tipping balance towards anti-cancer immunity. This image was created with BioRender.com.

Language: Английский

Citations

11

Tumor microenvironment-sensitive polymeric nanoparticles for synergetic chemo-photo therapy DOI
Tingting Hu, Chao Shen, Xueyan Wang

et al.

Chinese Chemical Letters, Journal Year: 2024, Volume and Issue: 35(11), P. 109562 - 109562

Published: Jan. 26, 2024

Language: Английский

Citations

8

Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives DOI Creative Commons
Yuqing Pan, Xiangdong Xue, Xing‐Jie Liang

et al.

Advanced NanoBiomed Research, Journal Year: 2024, Volume and Issue: 4(4)

Published: Jan. 26, 2024

This review is aiming to systematically elucidate the unique role of nanotechnology in optimizing therapeutic modalities for combinatorial cancer immunotherapy, which enables synergistic integration multiple treatment strategies. In particular, has enabled combination immunotherapy with physical therapies, chemotherapy, metal therapy, and nucleic acid therapy. each regimen, nanocarriers play multifaceted roles by achieving targeted codelivery different therapeutics individual modality. offers new paradigms guide precision medicine treatment. Immunotherapy alone unlikely achieve personalized cancer, are needed future. To overcome technical bottlenecks realize precise regulation tumor microenvironment treatment, it crucial develop novel nanosystems integrated sensing, targeting, functionalities.

Language: Английский

Citations

6

Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication DOI Creative Commons
Mengyuan He, Aixue Li, Yongwei Gu

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Oct. 6, 2024

Inspired by the concept of "natural camouflage," biomimetic drug delivery systems have emerged to address limitations traditional synthetic nanocarriers, such as poor targeting, susceptibility identification and clearance, inadequate biocompatibility, low permeability, systemic toxicity. Biomimetic nanocarriers retain proteins, nucleic acids, other components parent cells. They not only facilitate but also serve communication media inhibit tumor This paper delves into mechanisms between various cell-derived cells, microenvironment, well their applications in delivery. In addition, additional capabilities conferred on modified targeting environmental responsiveness, are outlined. Finally, we propose future development directions for hoping inspire researchers design efforts ultimately achieve clinical translation.

Language: Английский

Citations

4

Nomogram Prediction of Response to Neoadjuvant Chemotherapy Plus Pembrolizumab in Locally Advanced Hypopharyngeal Squamous Cell Carcinoma DOI Creative Commons
Zhangwei Hu, Yi Chen,

Renqiang Ma

et al.

Journal of Otolaryngology - Head and Neck Surgery, Journal Year: 2025, Volume and Issue: 54

Published: Jan. 1, 2025

Language: Английский

Citations

0

Erythrocyte membrane vesicles as drug delivery systems: A systematic review of preclinical studies on biodistribution and pharmacokinetics DOI Creative Commons
Nina Kostevšek

Biomaterials Advances, Journal Year: 2025, Volume and Issue: 170, P. 214234 - 214234

Published: Feb. 14, 2025

This systematic review aims to summarize the development of erythrocyte membrane vesicles (EMVs) as drug delivery carriers, with a focus on elucidating their fate in terms biodistribution and pharmacokinetics preclinical studies. The PubMed database was systematically reviewed search for original peer-reviewed published studies use EMVs findings, following PRISMA guidelines. A total 142 articles matched selection criteria were included review. For each study, parameters extracted: type active pharmaceutical ingredient (API) encapsulated into EMVs, EMVs-API formulation method final particle size, surface modifications targeting, cell lines animal models used crucial treatment data, data finally, where applicable, about circulation time blood half-life. size did not vary significantly among different methods. complete list is provided. Circulation times half-life grouped per type. most commonly type, BALB/c mice, average EMV-API calculated be 10.4 h, all cases, up 10-fold increase observed compared that free API. Surface drastically change but improve target tissue accumulation. critical weaknesses analysed identified. Key points future are provided fill current knowledge gaps quality publications.

Language: Английский

Citations

0

Immunomodulatory Prodrug Micelles Imitate Mild Heat Effects to Reshape Tumor Microenvironment for Enhanced Cancer Immunotherapy DOI Creative Commons

Thi-Lan-Huong Ngo,

Kuan-Lin Wang,

Wen‐Yu Pan

et al.

ACS Nano, Journal Year: 2024, Volume and Issue: 18(7), P. 5632 - 5646

Published: Feb. 12, 2024

Physical stimulation with mild heat possesses the notable ability to induce immunomodulation within tumor microenvironment (TME). It transforms immunosuppressive TME into an immune-active state, making tumors more receptive immune checkpoint inhibitor (ICI) therapy. Transient receptor potential vanilloid 1 (TRPV1), which can be activated by heat, holds these alterations in TME. However, achieving precise temperature control while protecting neighboring tissues remains a significant challenge when using external sources. Taking inspiration from sensation elicited capsaicin-containing products activating TRPV1, this study employs capsaicin chemically stimulate imitating immunomodulatory benefits akin those induced heat. This involves developing glutathione (GSH)-responsive prodrug micelle system deliver and ICI (BMS202) concurrently. Following intravenous administration, micelles accumulate at site through enhanced permeability retention effect. Within GSH-rich TME, disintegrate release BMS202. The released activates TRPV1 expressed enhancing programmed death ligand expression on cell surfaces promoting T recruitment rendering it immunologically active. Meanwhile, liberated BMS202 blocks checkpoints cells cells, recruited ultimately eradicating tumors. innovative strategy represents comprehensive approach fine-tune significantly amplifying effectiveness of cancer immunotherapy exploiting pathway enabling situ

Language: Английский

Citations

3

Dual Stimuli-Responsive Micelles for Imaging-Guided Mitochondrion-Targeted Photothermal/Photodynamic/Chemo Combination Therapy-Induced Immunogenic Cell Death DOI Creative Commons
Yan Liang, Pingyu Wang,

Ze-Yun Liu

et al.

International Journal of Nanomedicine, Journal Year: 2023, Volume and Issue: Volume 18, P. 4381 - 4402

Published: Aug. 1, 2023

Introduction: As the special modality of cell death, immunogenic death (ICD) could activate immune response. Phototherapy in combination with chemotherapy (CT) is a particularly efficient tumor ICD inducing method that overcome defects monotherapies. Methods: In this study, new dual stimuli-responsive micelles were designed and prepared for imaging-guided mitochondrion-targeted photothermal/photodynamic/CT therapy through ICD. A dual-sensitive methoxy-polyethylene glycol-SS-poly(L-γ-glutamylglutamine)-SS-IR780 (mPEG-SS-PGG-SS-IR780) polymer was synthesized by grafting IR780 biodegradable di-carboxyl PGG as backbone, mPEG-SS-PGG-SS-IR780/paclitaxel (mPEG-SS-PGG-SS-IR780/PTXL MCs) encapsulating PTXL hydrophobic core. Results: In-vivo -vitro results demonstrated three-mode inhibited growth enhanced therapeutic efficacy immunotherapy. The mPEG-SS-PGG-SS-IR780/PTXL MCs able to facilitate endocytosis nanoparticles. They also capable promoting disintegration accelerating release. induced mitochondrial dysfunction directly targeting mitochondria, considering thermo- reactive oxygen species (ROS) sensitivity mitochondria. Furthermore, play diagnostic roles via imaging capabilities. Conclusion: summary, study formulated high-efficiency nanoscale platform great potential combined tumors Keywords: photothermal/photodynamic/chemo therapy, dual-stimuli-responsive, poly(amino acid)s micelles, mitochondria

Language: Английский

Citations

4

Environment-responsive dopamine nanoplatform for tumor synergistic therapy DOI Creative Commons

Chunmin Deng,

Hao Zhang, Song Li

et al.

Discover Oncology, Journal Year: 2024, Volume and Issue: 15(1)

Published: Aug. 5, 2024

Nanoparticle-based photothermal therapy (PTT) has emerged as a promising approach in tumor treatment due to its high selectivity and low invasiveness. However, the penetration of near-infrared light (NIR) is limited, leading it fails induce damage deep-seated cells within tissue. Additionally, inefficient uptake nanoparticles by results suboptimal outcomes for PTT. In this study, we utilized adhesive properties material, polydopamine (PDA), which can successfully load photosensitizer indocyanine green (ICG) chemotherapeutic drug doxorubicin (DOX) achieve chemotherapy synergy (PDA/DOX&ICG), aiming compensate defects single treatment. To extending blood circulation time PDA/DOX&ICG nanoparticles, evading clearance body immune system achieving targeted delivery tissues, protective envelopment was created using erythrocyte membranes modified with folate acid (FA-EM). After reaching tissue, obtained FA-EM@PDA/DOX&ICG specific bind receptors on surface cells, improve behavior release loaded DOX ICG response unique microenvironment. ICG, typical photosensitizer, significantly enhances conversion performance thus inducing damage. vitro vivo experimental demonstrated that coordinated NIR not only effectively inhibits growth, but also exhibits superior biocompatibility, mitigating DOX-induced tissue

Language: Английский

Citations

1

Carbohydrate polymer-based nanoparticles with cell membrane camouflage for cancer therapy: A review DOI

Haijia Hou,

Xuejian Liu, Jun Liu

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 289, P. 138620 - 138620

Published: Dec. 13, 2024

Language: Английский

Citations

1